Predilution Versus postdilution during continuous venovenous hemofiltration: A comparison of circuit thrombogenesis

ASAIO Journal

Volumn 52, Issue 4, 2006, Pages 416-422

  De Pont, Anne Cornélie J M ^a,b   Bouman, Catherine S C ^a   Bakhtiari, Kamran ^a   Schaap, Marianne C L ^a   Nieuwland, Rienk ^a   Sturk, Augueste ^a   Hutten, Barbara A ^a   De Jonge, Evert ^a   Vroom, Margreeth B ^a   Meijers, Joost C M ^a   Büller, Harry R ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; FILTRATION; NUMERICAL METHODS; PATIENT TREATMENT; PRESSURE EFFECTS; ULTRAFILTRATION;

EXTRACORPOREAL CIRCUIT PRESSURE; PROTHROMBIN; THROMBOGENESIS; VENOVENOUS HEMOFILTRATION;

BIOMEDICAL ENGINEERING;

ANTITHROMBIN; PROTHROMBIN; THROMBIN;

ADULT; AGED; ARTICLE; BLOOD FLOW; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DILUTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACORPOREAL CIRCULATION; FEMALE; FLOW CYTOMETRY; HEMOFILTRATION; HUMAN; MALE; SURVIVAL TIME; THROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOGENESIS;

ADULT; AGED; ANTICOAGULANTS; APACHE; BLOOD COAGULATION; BLOOD FLOW VELOCITY; BLOOD PLATELETS; BLOOD PRESSURE; CRITICAL ILLNESS; CROSS-OVER STUDIES; FEMALE; HEMATOCRIT; HEMOFILTRATION; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NADROPARIN; PARTIAL THROMBOPLASTIN TIME; PLATELET ACTIVATION; PLATELET COUNT; PROTHROMBIN TIME; THROMBIN; THROMBOEMBOLISM; UREA;

EID: 33746787670     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mat.0000227733.03278.5f     Document Type: Article

References (21)

1. Abramson S, Niles JL: Anticoagulation in continuous renal replacement therapy. Curr Opin Nephrol Hypertens 8: 701-707, 1999.
2. Gabutti L, Marone C, Colucci G, et al: Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 28: 1419-1425, 2002.
3. Horrow JC: Protamine: a review of its toxicity. Anesth Analg 64: 348-361, 1985.
4. Kaplan AA: Predilution versus postdilution for continuous arteriovenous hemofiltration. Trans Am Soc Artif Intern Organs 31: 28-32, 1985.
5. Uchino S, Fealy N, Baldwin I, et al: Pre-dilution vs post-dilution during continuous venovenous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract 94: c94-c98, 2003.
6. Van der Voort PH, Gerritsen RT, Kuiper MA, et al: Filter run time in CVVH: pre-versus postdilution and nadroparin versus regional heparin-protamine anticoagulation. Blood Purification 23: 175-180, 2005.
7. Maquelin KN, Nieuwland R, Lentjes EG, et al: Aprotinin administration in the pericardial cavity does not prevent platelet activation. J Thorac Cardiovasc Surg 120: 552-557, 2000.
8. Stefanidis I, Heintz B, Frank D, et al: Influence of hematocrit on hemostasis in continuous venovenous hemofiltration during acute renal failure. Kidney Int 56(suppl 72): S51-S55,1999.
9. Cardigan RA, McGloin H, Mackie IJ, et al: Activation of the tissue factor pathway occurs during continuous venovenous hemofiltration. Kidney Int 55: 1568-1574, 1999.
10. Kozek-Langenecker SA, Spiss CK, Michalek-Sauberer A, et al: Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Crit Care Med 31: 864-868, 2003.
11. Kozek-Langenecker SA, Spiss CK, Gamsjager T, et al: Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous hemofiltration: a randomized controlled trial. Wien Klin Wochenschr 114: 96-101, 2002.
12. Clark WR, Gao D: Properties of membranes used for hemodialysis therapy. Semin Dial 15: 191-195, 2002.
13. Lee AJ, Mowbray PI, Lowe GD, et al: Blood viscosity and elevated intima-media thickness in men and women: the Edinburgh artery study. Circulation 97: 1467-1473, 1998.
14. Baldwin I, Bellomo R, Koch B: Blood flow reductions during continuous renal replacement therapy and circuit life. Intensive Care Med 30: 2074-2079, 2004.
15. de Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, Zandstra DF: Nadroparin versus dalteparin anticoagulation in high-volume continuous venovenous hemofiltration: a double-blind, randomized, crossover study. Crit Care Med 28: 421-425, 2000.
16. Crowley JP, Metzger J, Assaf A, et al: Low density lipoprotein cholesterol and whole blood viscosity. Ann Clin Lab Sci 24: 533-541, 1994.
17. Kroll MH, Hellums JD, McIntire LV, et al: Platelets and shear stress. Blood 88: 1525-1541, 1996.
18. Goto S, Ikeda Y, Saldivar E, Ruggeri ZM: Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 101: 479-486, 1998.
19. Sakariassen KS, Hanson SR, Cadroy Y: Methods and models to evaluate shear-dependent and surface-reactivity dependent antithrombotic activity. Thromb Res 104: 149-174, 2001.
20. David S, Boström M, Cambi V: Predilution hemofiltration: clinical experience and removal of small molecular weight solutes. Int J Artif Organs 18: 743-750, 1995.
21. Weigert AL, Schafer AI: Uremic bleeding: pathogenesis and therapy. Am J Med Sci 316: 94-104, 1998.